Fig. 9From: Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approachesCo-crystallized ligands redocked in histone deacetylase (HDAC3), hydrogen bonds (green) and the pi interactions are represented in purple lines with mapping surface showing thymoquinone (TQ), piperine (PIP), and sorafenib (SOR) occupying the active pocket of HDACBack to article page